Ciprofloxacin Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Ciprofloxacin Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING





WARNINGS

CIPROFLOXACIN HYDROCHLORIDE DESCRIPTION


Ciprofloxacin Hydrochloride


Ciprofloxacin Hydrochloride



CLINICAL PHARMACOLOGY

Absorption:


Dose (mg)Maximum Serum Concentrations (Area Under Curve (AUC) (hr/mL)


Steady-state Pharmacokinetic Parameters Following Multiple Oral and I.V. Doses


Distribution:




Metabolism:

CONTRAINDICATIONS WARNINGSPRECAUTIONS: Drug Interactions).
Excretion:

The serum elimination half-life in subjects with normal renal function is approximately 4 hours. Approximately 40 to 50% of an orally administered dose is excreted in the urine as unchanged drug. After a 250 mg oral dose, urine concentrations of ciprofloxacin usually exceed 200during the first two hours and are approximately 30at 8 to 12 hours after dosing. The urinary excretion of ciprofloxacin is virtually complete within 24 hours after dosing. The renal clearance of ciprofloxacin, which is approximately 300 mL/minute, exceeds the normal glomerular filtration rate of 120 mL/minute. Thus, active tubular secretion would seem to play a significant role in its elimination. Co-administration of probenecid with ciprofloxacin results in about a 50% reduction in the ciprofloxacin renal clearance and a 50% increase in its concentration in the systemic circulation. Although bile concentrations of ciprofloxacin are several fold higher than serum concentrations after oral dosing, only a small amount of the dose administered is recovered from the bile as unchanged drug. An additional 1 to 2% of the dose is recovered from the bile in the form of metabolites. Approximately 20 to 35% of an oral dose is recovered from the feces within 5 days after dosing. This may arise from either biliary clearance or transintestinal elimination.

Drug-drug Interactions:

When Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg is given concomitantly with food, there is a delay in the absorption of the drug, resulting in peak concentrations that occur closer to 2 hours after dosing rather than 1 hour. The overall absorption of Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg however, is not substantially affected. Concurrent administration of antacids containing magnesium hydroxide or aluminum hydroxide may reduce the bioavailability of ciprofloxacin by as much as 90%. (SeePRECAUTIONS.)

The serum concentrations of ciprofloxacin and metronidazole were not altered when these two drugs were given concomitantly.

Concomitant administration with tizanidine is contraindicated. (SeeCONTRAINDICATIONS.)

Concomitant administration of ciprofloxacin with theophylline decreases the clearance of theophylline resulting in elevated serum theophylline levels and increased risk of a patient developing CNS or other adverse reactions. Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration. (SeeWARNINGS:PRECAUTIONS.)
Special Populations:

Pharmacokinetic studies of the oral (single dose) and intravenous (single and multiple dose) forms of ciprofloxacin indicate that plasma concentrations of ciprofloxacin are higher in elderly subjects (> 65 years) as compared to young adults. Although the Cmax is increased 16- 40%, the increase in mean AUC is approximately 30%, and can be at least partially attributed to decreased renal clearance in the elderly. Elimination half-life is only slightly (~20%) prolonged in the elderly. These differences are not considered clinically significant. (SeePRECAUTIONS: Geriatric Use.)

In patients with reduced renal function, the half-life of ciprofloxacin is slightly prolonged. Dosage adjustments may be required. (SeeDOSAGE AND ADMINISTRATION.)

In preliminary studies in patients with stable chronic liver cirrhosis, no significant changes in ciprofloxacin pharmacokinetics have been observed. The kinetics of ciprofloxacin in patients with acute hepatic insufficiency, however, have not been fully elucidated.


MICROBIOLOGY





INDICATIONS AND USAGE
Aerobic gram-positive microorganisms







Aerobic gram-negative microorganisms













INDICATIONS AND USAGEINHALATIONAL ANTHRAXADDITIONAL INFORMATION





Aerobic gram-positive microorganisms





Aerobic gram-negative microorganisms










Susceptibility Tests

Dilution Techniques:




MIC (Interpretation



MIC (Interpretation





MIC (Interpretation





OrganismMIC (



Diffusion Techniques:






Zone Diameter (mm)Interpretation




Zone Diameter (mm)Interpretation





Zone Diameter (mm)Interpretation





OrganismZone Diameter (mm)



INDICATIONS & USAGE

DOSAGE AND ADMINISTRATION
Adult Patients:

Urinary Tract Infections

Acute Uncomplicated Cystitis in females

Chronic Bacterial Prostatitis

Lower Respiratory Tract Infections



Acute Sinusitis

Skin and Skin Structure Infections

Bone and Joint Infections

Complicated Intra-Abdominal Infections

Infectious Diarrhea


Typhoid Fever(Enteric Fever)



Uncomplicated cervical and urethral gonorrhea
Pediatric patients (1 to 17 years of age):

Complicated Urinary Tract Infections and Pyelonephritis

WARNINGSPRECAUTIONS, Pediatric UseADVERSE REACTIONSCLINICAL STUDIES

ANIMAL PHARMACOLOGY

Adult and Pediatric Patients:

Inhalational anthrax

INHALATIONAL ANTHRAXADDITIONAL INFORMATION






CIPROFLOXACIN HYDROCHLORIDE CONTRAINDICATIONS



PRECAUTIONS: Drug Interactions

WARNINGS

Tendinopathy and Tendon Rupture:


Pregnant Women:

THE SAFETY AND EFFECTIVENESS OF CIPROFLOXACIN IN PREGNANT AND LACTATING WOMEN HAVE NOT BEEN ESTABLISHED.PRECAUTIONS: PregnancyNursing Mothers
Pediatrics:

INDICATIONS AND USAGEADVERSE REACTIONS

ANIMAL PHARMACOLOGY
Cytochrome P450 (CYP450):


Central Nervous System Disorders:

PRECAUTIONS: GeneralInformation for PatientsDrug InteractionsADVERSE REACTIONS
Theophylline:

SERIOUS AND FATAL REACTIONS HAVE BEEN REPORTED IN PATIENTS RECEIVING CONCURRENT ADMINISTRATION OF CIPROFLOXACIN AND THEOPHYLLINE.
Hypersensitivity Reactions:




  • ●     vasculitis; arthralgia; myalgia; serum sickness;
  • ●     allergic pneumonitis;
  • ●     interstitial nephritis; acute renal insufficiency or failure;
  • ●     hepatitis; jaundice; acute hepatic necrosis or failure;
  • ●     anemia, including hemolytic and aplastic; thrombocytopenia, including thrombotic thrombocytopenic purpura; leukopenia; agranulocytosis; pancytopenia; and/or other hematologic abnormalities.
PRECAUTIONS: Information for PatientsADVERSE REACTIONS

Pseudomembranous Colitis:




Peripheral neuropathy:


Syphilis:



PRECAUTIONS

General:

ANIMAL PHARMACOLOGY

Central Nervous System:

WARNINGSInformation for PatientsDrug Interactions

Renal Impairment:

DOSAGE AND ADMINISTRATION

Photosensitivity/Phototoxicity:

ADVERSE REACTIONS/Post-Marketing Adverse Events





INFORMATION FOR PATIENTS


  • ●     that antibacterial drugs including Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Ciprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg or other antibacterial drugs in the future.
  • ●     that ciprofloxacin may be taken with or without meals and to drink fluids liberally. As with other quinolones, concurrent administration of ciprofloxacin with magnesium/aluminum antacids, or sucralfate, Videx
  • ●     that ciprofloxacin may be associated with hypersensitivity reactions, even following a single dose, and to discontinue the drug at the first sign of a skin rash or other allergic reaction.
  • ●     that photosensitivity/phototoxicity has been reported in patients receiving quinolones. Patients should minimize or avoid exposure to natural or artificial sunlight (tanning beds or UVA/B treatment) while taking quinolones. If patients need to be outdoors while using quinolones, they should wear loose-fitting clothes that protect skin from sun exposure and discuss other sun protection measures with their physician. If a sunburn-like reaction or skin eruption occurs, patients should contact their physician.
  • ●     that peripheral neuropathies have been associated with ciprofloxacin use. If symptoms of peripheral neuropathy including pain, burning, tingling, numbness and/or weakness develop, they should discontinue treatment and contact their physicians.
  • ●     that ciprofloxacin may cause dizziness and lightheadedness; therefore, patients should know how they react to this drug before they operate an automobile or machinery or engage in activities requiring mental alertness or coordination.
  • ●     that ciprofloxacin increases the effects of tizanidine (ZanaflexPatients should not use ciprofloxacin if they are already taking tizanidine.
  • ●     that ciprofloxacin may increase the effects of theophylline and caffeine. There is a possibility of caffeine accumulation when products containing caffeine are consumed while taking quinolones.
  • ●     that convulsions have been reported in patients receiving quinolones, including ciprofloxacin, and to notify their physician before taking this drug if there is a history of this condition.
  • ●     that ciprofloxacin has been associated with an increased rate of adverse events involving joints and surrounding tissue structures (like tendons) in pediatric patients (less than 18 years of age). Parents should inform their child's physician if the child has a history of joint-related problems before taking this drug. Parents of pediatric patients should also notify their child's physician of any joint-related problems that occur during or following ciprofloxacin therapy. (SeeWARNINGS,PRECAUTIONS, Pediatric UseandADVERSE REACTIONS.)
  • ●     that diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.



DRUG INTERACTIONS




WARNINGS



DOSAGE AND ADMINISTRATION



















CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY


























PREGNANCY

Teratogenic Effects









WARNINGS

WARNINGS

NURSING MOTHERS



PEDIATRIC USE

ANIMAL PHARMACOLOGY
Inhalational Anthrax (Post-Exposure)

DOSAGE AND ADMINISTRATIONINHALATIONAL ANTHRAXADDITIONAL INFORMATION
Complicated Urinary Tract Infection and Pyelonephritis
ADVERSE REACTIONSCLINICAL STUDIES

Cystic Fibrosis



GERIATRIC USE

BOXED WARNINGWARNINGSADVERSE REACTIONS/Post-Marketing Adverse Event Reports

CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION



CIPROFLOXACIN HYDROCHLORIDE ADVERSE REACTIONS

Adverse Reactions in Adult Patients:
































Adverse Reactions in Pediatric Patients:








CiprofloxacinComparator





Post-Marketing Adverse Event Reports:



PRECAUTIONS

INHALATIONAL ANTHRAXADDITIONAL INFORMATION
Adverse Laboratory Changes:











OVERDOSAGE






DOSAGE & ADMINISTRATION

ADULTS





ADULT DOSAGE GUIDELINESInfectionSeverityDoseFrequencyUsual DurationsINHALATIONAL ANTHRAXADDITIONAL INFORMATION
Conversion of I.V. to Oral Dosing in Adults:

CLINICAL PHARMACOLOGY

Cipro Oral DosageEquivalent Cipro I.V. Dosage
Adults with Impaired Renal Function:



Creatinine Clearance (mL/min)Dose











DOSAGE AND ADMINISTRATION - PEDIATRICS

ADVERSE REACTIONSCLINICAL STUDIES



InfectionRoute of AdministrationDose (mg/kg)FrequencyTotal DurationINHALATIONAL ANTHRAXADDITIONAL INFORMATION


HOW SUPPLIED


StrengthNDC CodeTablet Identification

STORAGE AND HANDLING



ANIMAL PHARMACOLOGY & OR TOXICOLOGY


WARNINGS








CLINICAL STUDIES

Complicated Urinary Tract Infection and PyelonephritisEfficacy in Pediatric Patients:









CiprofloxacinComparator
INHALATIONAL ANTHRAX IN ADULTS AND PEDIATRICSADDITIONAL INFORMATION

DOSAGE AND ADMINISTRATIONPRECAUTIONS, Pediatric Use







REFERENCES














SPL MEDGUIDE


CCiprofloxacin Tablets USP, 250 mg, 500 mg and 750 mg


What is the most important information I should know about Ciprofloxacin Tablets USP ?

Tendon rupture or swelling of the tendon (tendinitis)
  • ●     Tendons are tough cords of tissue that connect muscles to bones.
  • ●     Pain, swelling, tears and inflammation of tendons including the back of the ankle (Achilles), shoulder, hand, or other tendon sites can happen in people of all ages who take fluoroquinolone antibiotics, including Ciprofloxacin Tablets USP. The risk of getting tendon problems is higher if you:
  • ●               are over 60 years of age
  • ●               are taking steroids (corticosteroids)
  • ●               have had a kidney, heart or lung transplant
  • ●     Swelling of the tendon (tendinitis) and tendon rupture (breakage) have also happened in patients who take fluoroquinolones who do not have the above risk factors.
  • ●     Other reasons for tendon ruptures can include:
  • ●               physical activity or exercise
  • ●               kidney failure
  • ●               tendon problems in the past, such as in people with rheumatoid arthritis (RA)
  • ●     Call your healthcare provider right away at the first sign of tendon pain, swelling or inflammation. Stop taking Ciprofloxacin Tablets USP until tendinitis or tendon rupture has been ruled out by your healthcare provider. Avoid exercise and using the affected area. The most common area of pain and swelling is the Achilles tendon at the back of your ankle. This can also happen with other tendons. Talk to your healthcare provider about the risk of tendon rupture with continued use of Ciprofloxacin Tablets USP. You may need a different antibiotic that is not a fluoroquinolone to treat your infection.
  • ●     Tendon rupture can happen while you are taking or after you have finished taking Ciprofloxacin Tablets USP. Tendon ruptures have happened up to several months after patients have finished taking their fluoroquinolone.
  • ●     Get medical help right away if you get any of the following signs or symptoms of a tendon rupture:
  • ●               hear or feel a snap or pop in a tendon area
  • ●               bruising right after an injury in a tendon area
  • ●               unable to move the affected area or bear weight
  • ●     See the sectionWhat are the possible side effects of Ciprofloxacin Tablets USP?for more information about side effects.

What is Ciprofloxacin Tablets USP?






Who should not take Ciprofloxacin Tablets USP?

  • ●     have ever had a severe allergic reaction to an antibiotic known as a fluoroquinolone, or are allergic to any of the ingredients in Ciprofloxacin Tablets USP. Ask your healthcare provider if you are not sure. See the list of ingredients in Ciprofloxacin Tablets USP at the end of this Medication Guide.
  • ●     also take a medicine called tizanidine (ZanaflexSerious side effects from tizanidine are likely to happen.

What should I tell my healthcare provider before taking Ciprofloxacin Tablets USP?
What is the most important information I should know about Ciprofloxacin Tablets USP?
Tell your healthcare provider about all your medical conditions, including if you:
  • ●     have tendon problems
  • ●     have central nervous system problems (such as epilepsy)
  • ●     have nerve problems
  • ●     have or anyone in your family has an irregular heartbeat, especially a condition calledQT prolongation
  • ●     have a history of seizures
  • ●     have kidney problems. You may need a lower dose of Ciprofloxacin Tablets USP if your kidneys do not work well.
  • ●     have rheumatoid arthritis (RA) or other history of joint problems
  • ●     have trouble swallowing pills
  • ●     are pregnant or planning to become pregnant. It is not known if Ciprofloxacin Tablets USP will harm your unborn child.
  • ●     are breast-feeding or planning to breast-feed. Ciprofloxacin Tablets USP passes into breast milk. You and your healthcare provider should decide whether you will take Ciprofloxacin Tablets USP or breast-feed.
Tell your healthcare provider about all the medicines you take,
  • ●     an NSAID (Non-Steroidal Anti-Inflammatory Drug). Many common medicines for pain relief are NSAIDs. Taking an NSAID while you take Ciprofloxacin Tablets USP or other fluoroquinolones may increase your risk of central nervous system effects and seizures. SeeWhat are the possible side effects of Ciprofloxacin Tablets USP?
  • ●     a blood thinner (warfarin, CoumadinJantoven
  • ●     tizanidine (ZanaflexYou should not take Ciprofloxacin Tablets USP if you are already taking tizanidine. SeeWho should not take Ciprofloxacin Tablets USP?
  • ●     theophylline (Theo-24ElixophyllinTheochronUniphylTheolair
  • ●     glyburide (MicronaseGlynaseDiabetaGlucovanceSeeWhat are the possible side effects of Ciprofloxacin Tablets USP?
  • ●     phenytoin (Fosphenytoin SodiumCerebyxDilantin-125DilantinExtended Phenytoin SodiumPrompt Penytoin SodiumPhenytek
  • ●     products that contain caffeine
  • ●     a medicine to control your heart rate or rhythm (antiarrhythmics) SeeWhat are the possible side effects of Ciprofloxacin Tablets USP?
  • ●     an anti-psychotic medicine
  • ●     a tricyclic antidepressant
  • ●     a water pill (diuretic)
  • ●     a steroid medicine. Corticosteroids taken by mouth or by injection may increase the chance of tendon injury. SeeWhat is the most important information I should know about Ciprofloxacin Tablets USP?
  • ●     methotrexate (Trexall
  • ●     Probenecid (ProbalanCol-probenecid
  • ●     Metoclopromide (ReglanReglan ODT
  • ●     Certain medicines may keep Ciprofloxacin Tablets USP from working correctly. Take Ciprofloxacin Tablets USP either 2 hours before or 6 hours after taking these products:
  • ●               an antacid, multivitamin, or other product that has magnesium, calcium, aluminum, iron, or zinc
  • ●               sucralfate (Carafate
  • ●               didanosine (VidexVidex EC



How should I take Ciprofloxacin Tablets USP?
  • ●      Take Ciprofloxacin Tablets USP exactly as prescribed by your healthcare provider.
  • ●     Take Ciprofloxacin Tablets USP in the morning and evening at about the same time each day. Swallow the tablet whole. Do not split, crush or chew the tablet. Tell your healthcare provider if you can not swallow the tablet whole.
  • ●     Ciprofloxacin Tablets USP can be taken with or without food.
  • ●     Ciprofloxacin Tablets USP should not be taken with dairy products (like milk or yogurt) or calcium-fortified juices alone, but may be taken with a meal that contains these products.
  • ●     Drink plenty of fluids while taking Ciprofloxacin Tablets USP.
  • ●     Do not skip any doses, or stop taking Ciprofloxacin Tablets USP even if you begin to feel better, until you finish your prescribed treatment, unless:
  • ●               you have tendon effects (seeWhat is the most important information I should know about Ciprofloxacin Tablets USP?),
  • ●               you have a serious allergic reaction (seeWhat are the possible side effects of Ciprofloxacin Tablets USP?), or
  • ●               your healthcare provider tells you to stop.
  • ●     This will help make sure that all of the bacteria are killed and lower the chance that the bacteria will become resistant to Ciprofloxacin Tablets USP. If this happens, Ciprofloxacin Tablets USP and other antibiotic medicines may not work in the future.
  • ●     If you miss a dose of Ciprofloxacin Tablets USP, take it as soon as you remember. Do not take two doses at the same time, and do not take more than two doses in one day.
  • ●     If you take too much, call your healthcare provider or get medical help immediately.
If you have been prescribed Ciprofloxacin Tablets USP after being exposed to anthrax:
  • ●     Ciprofloxacin Tablets USP has been approved to lessen the chance of getting anthrax disease or worsening of the disease after you are exposed to the anthrax bacteria germ.
  • ●     Take Ciprofloxacin Tablets USP exactly as prescribed by your healthcare provider. Do not stop taking Ciprofloxacin Tablets USP without talking with your healthcare provider. If you stop taking Ciprofloxacin Tablets USP too soon, it may not keep you from getting the anthrax disease.
  • ●     Side effects may happen while you are taking Ciprofloxacin Tablets USP. When taking your Ciprofloxacin Tablets USP to prevent anthrax infection, you and your healthcare provider should talk about whether the risks of stopping Ciprofloxacin Tablets USP too soon are more important than the risks of side effects with Ciprofloxacin Tablets USP.
  • ●     If you are pregnant, or plan to become pregnant while taking Ciprofloxacin Tablets USP, you and your healthcare provider should decide whether the benefits of taking Ciprofloxacin Tablets USP for anthrax are more important than the risks.

What should I avoid while taking Ciprofloxacin Tablets USP?
  • ●      Ciprofloxacin Tablets USP can make you feel dizzy and lightheaded. Do not drive, operate machinery, or do other activities that require mental alertness or coordination until you know how Ciprofloxacin Tablets USP affects you.
  • ●     Avoid sunlamps, tanning beds, and try to limit your time in the sun. Ciprofloxacin Tablets USP can make your skin sensitive to the sun (photosensitivity) and the light from sunlamps and tanning beds. You could get severe sunburn, blisters or swelling of your skin. If you get any of these symptoms while taking Ciprofloxacin Tablets USP, call your healthcare provider right away. You should use a sunscreen and wear a hat and clothes that cover your skin if you have to be in sunlight.

What are the possible side effects of Ciprofloxacin Tablets USP?
  • ●      Ciprofloxacin Tablets USP can cause side effects that may be serious or even cause death. SeeWhat is the most important information I should know about Ciprofloxacin Tablets USP?

  •      Central Nervous System effects:Seizures have been reported in people who take fluoroquinolone antibiotics including Ciprofloxacin Tablets USP. Tell your healthcare provider if you have a history of seizures. Ask your healthcare provider whether taking Ciprofloxacin Tablets USP will change your risk of having a seizure.     

  • ●               feel dizzy
  • ●               seizures
  • ●               hear voices, see things, or sense things that are not there (hallucinations)
  • ●               feel restless
  • ●               tremors
  • ●               feel anxious or nervous
  • ●               confusion
  • ●               depression
  • ●               trouble sleeping
  • ●               nightmares
  • ●               feel more suspicious (paranoia)
  • ●               suicidal thoughts or acts
  •      Serious allergic reactions:Allergic reactions can happen in people taking fluoroquinolones, including Ciprofloxacin Tablets USP, even after only one dose. Stop taking Ciprofloxacin Tablets USP and get emergency medical help right away if you get any of the following symptoms of a severe allergic reaction:
  • ●               hives
  • ●               trouble breathing or swallowing
  • ●               swelling of the lips, tongue, face
  • ●               throat tightness, hoarseness
  • ●               rapid heartbeat
  • ●               faint
  • ●               yellowing of the skin or eyes. Stop taking Ciprofloxacin Tablets USP and tell your healthcare provider right away if you get yellowing of your skin or white part of your eyes, or if you have dark urine. These can be signs of a serious reaction to Ciprofloxacin Tablets USP (a liver problem).
  •      Skin rash     

  •      Serious heart rhythm changes(QT prolongation and torsade de pointes)     

  • ●               who are elderly
  • ●               with a family history of prolonged QT interval
  • ●               with low blood potassium (hypokalemia)
  • ●               who take certain medicines to control heart rhythm (antiarrhythmics)
  •      Intestine infection (Pseudomembranous colitis)     

  •      Changes in sensation and possible nerve damage(Peripheral Neuropathy)     

  • ●               pain
  • ●               burning
  • ●               tingling
  • ●               numbness
  • ●               weakness


  •      Low blood sugar(hypoglycemia)     

  •      Sensitivity to sunlight(photosensitivity)     
What should I avoid while taking Ciprofloxacin Tablets USP?
  •      Joint Problems     



  • ●               nausea
  • ●               headache
  • ●               diarrhea
  • ●               vomiting
  • ●               vaginal yeast infection
  • ●               changes in liver function tests
  • ●               pain or discomfort in the abdomen



How should I store Ciprofloxacin Tablets USP?
  • ●      Store Ciprofloxacin Tablets USP below 86(30
Keep Ciprofloxacin Tablets USP and all medicines out of the reach of children.

General Information about Ciprofloxacin Tablets USP




What are the ingredients in Ciprofloxacin Tablets USP?
  • ●      Active ingredient: ciprofloxacin
  • ●     Inactive ingredients: pregelatinized starch, microcrystalline cellulose, colloidal silicon dioxide, crospovidone, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol and purified water


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-854(NDC:16571-412)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CIPROFLOXACIN HYDROCHLORIDE CIPROFLOXACIN 500 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
cellulose, microcrystalline
SILICON DIOXIDE
CROSPOVIDONE
MAGNESIUM STEARATE
HYPROMELLOSES
titanium dioxide
polyethylene glycol
water

Product Characteristics

Color Size Imprint Code Shape
white 18 mm P;500 BULLET

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-854-01 1 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076639 2011-12-12


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.